These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6201487)

  • 21. Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy.
    Kishi Y; Schmelzer JD; Yao JK; Zollman PJ; Nickander KK; Tritschler HJ; Low PA
    Diabetes; 1999 Oct; 48(10):2045-51. PubMed ID: 10512372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes.
    Gabbay KH; Merola LO; Field RA
    Science; 1966 Jan; 151(3707):209-10. PubMed ID: 5907911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of sorbitol pathway in neuropathy.
    Gabbay KH
    Adv Metab Disord; 1973; 2():Suppl 2:417-32. PubMed ID: 4269012
    [No Abstract]   [Full Text] [Related]  

  • 24. Relevance of the early and advanced Maillard reaction in diabetic neuropathy.
    Monnier VM; Miyata S; Nagaraj RH; Sell DR
    Diabet Med; 1993; 10 Suppl 2():103S-106S. PubMed ID: 7687529
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pathogenesis of angio- and neuropathies in patients with diabetes mellitus].
    Draznin NM
    Sov Med; 1973 Dec; 36(12):17-21. PubMed ID: 4779359
    [No Abstract]   [Full Text] [Related]  

  • 26. The aldose reductase controversy.
    Frank RN
    Diabetes; 1994 Feb; 43(2):169-72. PubMed ID: 8288039
    [No Abstract]   [Full Text] [Related]  

  • 27. Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy.
    Greene DA; Lattimer S; Ulbrecht J; Carroll P
    Diabetes Care; 1985; 8(3):290-9. PubMed ID: 2988888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of sorbinil on axonal transport in streptozotocin-diabetic rats.
    Willars GB; Tomlinson DR; Robinson JP
    Metabolism; 1986 Apr; 35(4 Suppl 1):66-70. PubMed ID: 2421136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
    Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K
    Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The sorbitol pathway and the complications of diabetes.
    Gabbay KH
    N Engl J Med; 1973 Apr; 288(16):831-6. PubMed ID: 4266466
    [No Abstract]   [Full Text] [Related]  

  • 31. [Disorders of sorbitol and myoinositol metabolism and the activity of sodium, potassium ATPase in the pathogenesis of peripheral neuropathy in patients with diabetes mellitus].
    Mosiewicz J; Grzywa M
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):56-8. PubMed ID: 1329048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral nerve biochemistry in diabetes.
    Clements RS
    Clin Physiol; 1985; 5 Suppl 5():19-22. PubMed ID: 2421965
    [No Abstract]   [Full Text] [Related]  

  • 34. Complications: neuropathy, pathogenetic considerations.
    Greene DA; Sima AA; Stevens MJ; Feldman EL; Lattimer SA
    Diabetes Care; 1992 Dec; 15(12):1902-25. PubMed ID: 1464245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defects of axonal transport in experimental diabetes that are unrelated to the sorbitol pathway.
    Tomlinson DR; Willars GB; Calthrop-Owen EF
    Exp Neurol; 1987 Apr; 96(1):194-202. PubMed ID: 2435570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a prostaglandin I2 derivative (iloprost) on peripheral neuropathy of diabetic rats.
    Ohno A; Kanazawa A; Tanaka A; Miwa T; Ito H
    Diabetes Res Clin Pract; 1992 Nov; 18(2):123-30. PubMed ID: 1282452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of diabetic neuropathy.
    N Engl J Med; 1989 Jan; 320(1):57-60. PubMed ID: 2909880
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of defects of axonal transport in experimental diabetes by aldose reductase inhibitors.
    Tomlinson DR; Willars GB; Robinson JP
    Drugs; 1986; 32 Suppl 2():15-8. PubMed ID: 2431858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway.
    Anitha M; Gondha C; Sutliff R; Parsadanian A; Mwangi S; Sitaraman SV; Srinivasan S
    J Clin Invest; 2006 Feb; 116(2):344-56. PubMed ID: 16453021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fast anterograde axonal transport in wasted and non-wasted diabetic rats; effects of aldose reductase inhibition.
    Whiteley SJ; Townsend J; Tomlinson DR; Willars GB
    Diabetes Res; 1986 Nov; 3(9):447-52. PubMed ID: 2435444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.